Wag! Group Co. (PET)
$
0.18
Key metrics
Financial statements
Free cash flow per share
-0.1523
Market cap
9.1 Million
Price to sales ratio
0.1458
Debt to equity
-5.6722
Current ratio
0.4597
Income quality
0.3164
Average inventory
0
ROE
21.6354
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Wag! Group Co. develops and supports a proprietary marketplace technology platform available as a website and mobile app that facilitates connections between independent pet caregivers and pet parents. The company's stock is identified with the symbol 'PET' in the market, reflecting its presence among investors. As it operates, the company maintains an operational profitability margin, indicated by an operating income ratio of -0.15. The total operating expenses amount to $75,605,000.00 which encompass various costs incurred in its operations. Highlighting the company's shareholder base, the weighted average number of shares outstanding is 44,719,000.00 which reflects the investment spread among stakeholders. Additionally, the diluted EPS is -$0.39 accounting for potential share dilution that may impact future earnings per share. Founded in 2015 and based in Purchase, New York, Wag! Group Co. provides essential service offerings including dog walking, pet sitting, boarding, advice from licensed pet experts, home visits, and training, catering to the diverse needs of pet parents. The stock is affordable at $0.18 making it suitable for budget-conscious investors who are looking for opportunities in the market. With a high average trading volume of 9,601,500.00 the stock exhibits strong liquidity, offering investors the ability to enter and exit positions with ease. With a market capitalization of $9,138,114.00 the company is classified as a small-cap player, which often signifies growth potential. It is a key player in the Software - Application industry, contributing significantly to the overall market landscape with its innovative services. Additionally, it belongs to the Technology sector, where it drives both innovation and growth, positioning itself as an important company in the pet care marketplace. This combination of affordability, liquidity, and market classification makes Wag! Group Co. a noteworthy option for various types of investors.
Is Wag! Group Co. (PET) a good investment?
Investing in Wag! Group Co. (PET) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C, with a Bullish outlook. Always conduct your own research before investing.
What is Wag! Group Co. (PET)'s stock forecast?
Analysts predict Wag! Group Co. stock to fluctuate between $0.08 (low) and $1.64 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Wag! Group Co.'s market capitalization?
As of 2025-07-11, Wag! Group Co.'s market cap is $9,138,114, based on 50,739,113 outstanding shares.
How does Wag! Group Co. compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Wag! Group Co. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Wag! Group Co. (PET) stock?
To buy Wag! Group Co. (PET) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for PET. Place an order (Market, Limit, etc.).
What is the best time to invest in Wag! Group Co.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
How did Wag! Group Co. perform in the last earnings report?
Revenue: $70,507,000 | EPS: -$0.39 | Growth: 11.43%.
Where can I find Wag! Group Co.'s investor relations reports?
Visit https://www.wagwalking.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Wag! Group Co.?
You can explore historical data from here
What is the all-time high and low for Wag! Group Co. stock?
All-time high: $10 (2022-08-10) | All-time low: $0.08 (2025-04-21).
What are the key trends affecting Wag! Group Co. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
globenewswire.com
MARKHAM, Ontario, July 10, 2025 (GLOBE NEWSWIRE) -- Pet Valu Holdings Ltd. (“Pet Valu” or the “Company”) (TSX: PET), the leading Canadian specialty retailer of pet food and pet-related supplies, will release its financial results for the second quarter of fiscal 2025 at approximately 6:30am ET on Tuesday, August 5, 2025, followed by a conference call at 8:30am ET.
businesswire.com
SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I) indications, today announced an update on its Phase 1b positron emission tomography (PET) trial of PIPE-791, a selective antagonist of the lysophosphatidic acid 1 (LPA1) receptor. The Company has completed enrollment of the healthy volunteer and.
businesswire.com
ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--FDA approves expanded indications for GE HealthCare's Vizamyl PET imaging agent for beta amyloid detection, enabling more precise care for Alzheimer's.
zacks.com
GEHC's Flyrcado gains momentum with FDA approval, CMS support, and expanding coverage in cardiac PET imaging.
businesswire.com
CHICAGO--(BUSINESS WIRE)--Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research collaboration with Stanford Medicine – with one of their key intentions being the development and research of innovative total body PET/CT technology.i This effort is expected to explore new clinical pathways and help enhance patient outcomes through innovative imaging solutions. “PET/CT has revolutionized the way we understand and treat disease by allowing us to visu.
globenewswire.com
Clermont-Ferrand (France), 27 May 2025 (17.45 CEST). CARBIOS (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, announces the signature of its first multi-year offtake contracts with L'ORÉAL and L'Occitane en Provence for biorecycled r-PET from its future commercial plant in Longlaville.
globenewswire.com
VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare and clinical stage drug development company, is pleased to announce it has entered into share exchange agreements to acquire 100% of the issued and outstanding shares of NoBrainer Imaging Centers, Inc. (“NIC”) (the “Transaction”). The Transaction moves Algernon into the Alzheimer's Disease (“AD”) diagnostic and treatment market, expanding on the Company's neurological research programs, and provides Algernon exclusive master franchise and licensing rights to open AD screening, diagnostic, and treatment centers across Canada and in multiple U.S. markets.
seekingalpha.com
Wag! Group Co. (NASDAQ:PET ) Q1 2025 Earnings Conference Call May 12, 2025 8:30 AM ET Company Participants Greg Robles - IR Garrett Smallwood - CEO and Chairman Adam Storm - President and Chief Product Officer Alec Davidian - CFO Operator Good morning. Welcome to the Wag!
globenewswire.com
TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) “Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announces that on March 31, 2025 it has entered into a joint clinical study with Massachusetts General Hospital (MGH) scientists to validate a novel positron emission tomography (PET) imaging technique to monitor myelin integrity and demyelination in people with multiple sclerosis (MS).
seekingalpha.com
Wag! Group Co. (NASDAQ:PET ) Q4 2024 Earnings Conference Call March 24, 2025 8:30 AM ET Company Participants Greg Robles - IR Garrett Smallwood - Chairman & CEO Adam Storm - President & Chief Product Officer Alec Davidian - CFO Conference Call Participants Jeremy Hamblin - Craig-Hallum Operator Good morning, and welcome to the Wag! Fourth Quarter and Full-Year 2024 Earnings Conference Call.
See all news
